ArticleCancer science2025

CML With Mutant ASXL1 Showed Decreased Sensitivity to TKI Treatment via Upregulation of the ALOX5-BLTR Signaling Pathway.

Naoki Miyashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.